Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Pullen

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|July 4, 2012
Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptorMark A Birrell, Sarah A Maher, James Buckley, et al.
Hepatology (Baltimore, Md.)|January 13, 2011
Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activityEvaggelia Liaskou, Marika Karikoski, Gary M Reynolds, et al.
Swiss Medical Weekly|March 26, 2025
Mental health of informal caregivers during the COVID-19 pandemic: a Swiss cohort studyCédric Follonier, Nick Pullen, Hélène Baysson, et al.
Swiss Medical Weekly|April 3, 2023
Parental willingness to have children vaccinated against COVID-19 in Geneva, Switzerland: a cross-sectional population-based studyHélène Baysson, Nick Pullen, Carlos De Mestral, et al.
Frontiers in Public Health|October 10, 2022
Socio-economic determinants of SARS-CoV-2 infection: Results from a population-based cross-sectional serosurvey in Geneva, SwitzerlandHugo-Alejandro Santa-Ramírez, Ania Wisniak, Nick Pullen, et al.
European Journal of Pharmacology|October 1, 2011
In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V(1A) receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245)Rachel Russell, Rachel Doyle, Jamie Turner, et al.
BMC Public Health|January 24, 2025
Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout: a cross-sectional analysis of a cohort studyAnshu Uppal, Nick Pullen, Hélène Baysson, et al.
Journal of Psychiatric Research|January 2, 2023
Prevalence and predictors of psychological distress before, during, and after a COVID-19 pandemic wave in Switzerland, 2021Stephanie Schrempft, Nick Pullen, Hélène Baysson, et al.
Swiss Medical Weekly|November 30, 2021
Perceptions of vaccination certificates among the general population in Geneva, SwitzerlandMayssam Nehme, Helene Baysson, Nick Pullen, et al.
Mabs|January 13, 2010
Preclinical development of monoclonal antibodies: considerations for the use of non-human primatesKathryn Chapman, Nick Pullen, Lee Coney, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|July 4, 2012
Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptorMark A Birrell, Sarah A Maher, James Buckley, et al.
Hepatology (Baltimore, Md.)|January 13, 2011
Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activityEvaggelia Liaskou, Marika Karikoski, Gary M Reynolds, et al.
Swiss Medical Weekly|March 26, 2025
Mental health of informal caregivers during the COVID-19 pandemic: a Swiss cohort studyCédric Follonier, Nick Pullen, Hélène Baysson, et al.
Swiss Medical Weekly|April 3, 2023
Parental willingness to have children vaccinated against COVID-19 in Geneva, Switzerland: a cross-sectional population-based studyHélène Baysson, Nick Pullen, Carlos De Mestral, et al.
Frontiers in Public Health|October 10, 2022
Socio-economic determinants of SARS-CoV-2 infection: Results from a population-based cross-sectional serosurvey in Geneva, SwitzerlandHugo-Alejandro Santa-Ramírez, Ania Wisniak, Nick Pullen, et al.
European Journal of Pharmacology|October 1, 2011
In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V(1A) receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245)Rachel Russell, Rachel Doyle, Jamie Turner, et al.
BMC Public Health|January 24, 2025
Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout: a cross-sectional analysis of a cohort studyAnshu Uppal, Nick Pullen, Hélène Baysson, et al.
Journal of Psychiatric Research|January 2, 2023
Prevalence and predictors of psychological distress before, during, and after a COVID-19 pandemic wave in Switzerland, 2021Stephanie Schrempft, Nick Pullen, Hélène Baysson, et al.
Swiss Medical Weekly|November 30, 2021
Perceptions of vaccination certificates among the general population in Geneva, SwitzerlandMayssam Nehme, Helene Baysson, Nick Pullen, et al.
Mabs|January 13, 2010
Preclinical development of monoclonal antibodies: considerations for the use of non-human primatesKathryn Chapman, Nick Pullen, Lee Coney, et al.
Pageof 6